MHE December 2020

December 27, 2020

In this final part of a six-part series, most are neutral-to-negative on chance of meaningful change.

December 26, 2020

In this fifth part of a six-part series, data said respondents split on the effect of the pandemic on value-based care

December 25, 2020

In this fourth part of a six-part series, data shows the pandemic severely affected revenues, expenses.

December 24, 2020

In this third of a six-part series, respondents give administration poor marks.

December 23, 2020

In this second of a six-part series, the biggest concern is short supply.

December 22, 2020

Respondents ranked the importance of healthcare issues.

December 21, 2020

The decrease in in-person healthcare this year because of the COVID-19 pandemic could be a good thing for telehealth and programs that deliver hospital-level care at home.

December 18, 2020

All the Medicare Advantage trend lines seem like they are northward bound. Enrollment, the number of plans, the number of companies selling those plans — they’re all up. So Avalere Health’s report last month on the percentage of beneficiaries in highly rated plans stood out — and not in a good way.

December 18, 2020

Many of the large insurers are responding by expanding into new markets.

December 17, 2020

Prostate cancer is often “indolent,” so it can be monitored and not treated right away.

December 16, 2020

Pre-pandemic momentum helped keep the number of novel therapies approved by the FDA high, and then COVID-19 tested just how fast the pipeline could adjust and expand.

December 15, 2020

With the 2020 election season nearly behind us, conventional wisdom is that we will have divided government: a Democratic president, a Republican Senate and a razor-thin Democratic majority in the U.S. House of Representatives. That combination is a recipe for compromise on President-elect Joe Biden’s healthcare priorities; namely, the federal response to the COVID-19 pandemic and adjustments to the ACA.